Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.



Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth company less than two months after it started.


0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Recent Comments

No comments to show.

Advertisement

Subscribe to Our Newsletter
Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...